Seeking Alpha

Keryx Biopharmaceuticals (KERX) prices an offering of 8.2M shares at $8.49 each, which is where...

Keryx Biopharmaceuticals (KERX) prices an offering of 8.2M shares at $8.49 each, which is where the stock closed yesterday. Including a greenshoe option of 1.2M shares, Keryx could raise up to $80.4M; the biotech plans to use the net proceeds to fund the launch of its kidney disease drug Zerenex. Shares +9.3% to $9.28. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs